冻干口服霍乱rBS-WC菌苗安全及保护效果评价的小鼠模型探讨

来源 :微生物学免疫学进展 | 被引量 : 0次 | 上传用户:storm_shen
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
本文仿照人口服免疫程序用小鼠为模型对冻干口服霍乱rBS-WC菌苗制品进行了安全及保护率评价。给KM小鼠口服三种不同剂量的rBS-WC菌苗后,无发病,无体重减轻,无死亡现象,表明该菌苗安全,无毒副作用。免疫组与安慰剂组小鼠用肠结扎攻毒试验评价保护效果,两组小鼠用吴江-2及滨-43活菌攻击后,免疫组显示良好保护作用(P<0.05)。此法可以用于口服型rBS-WC菌苗的评价,但也存在需要动物数较多,个体间差异较大,手术较麻烦的问题。 This article modeled the human oral immunization program using mouse as a model of safety and protection rate of lyophilized oral cholera rBS-WC vaccine products. KM mice were orally administered three different doses of rBS-WC vaccine, no disease, no weight loss, no death, indicating that the vaccine safe, non-toxic side effects. Immunization group and placebo group mice with intestinal ligation challenge test to evaluate the protective effect of two groups of mice with Wujiang-2 and -43 live bacteria attack, the immune group showed good protective effect (P <0.05). This method can be used for oral rBS-WC vaccine evaluation, but there are also the need for more animals, large differences between individuals, the operation is more cumbersome problems.
其他文献